US launches trial for blood tests that promise to catch cancers earlier
[ad_1] Questions remain about how to interpret MCED test results. Only some blood tests [more…]
[ad_1] Questions remain about how to interpret MCED test results. Only some blood tests [more…]
[ad_1] Text size New Jersey-based Merck has a market value of more than $234 billion. [more…]
[ad_1] Merck MRK 0.53% & Co. is in advanced talks to acquire Seagen Inc. [more…]
[ad_1] The ad reads like an offer of salvation: Cancer kills many people. But [more…]
[ad_1] One from Verita Life, in Bangkok, Thailand, targeted Australians like Autar, falsely claiming [more…]
[ad_1] Merck & Co. is pushing forward with a potential deal for biotech Seagen [more…]
[ad_1] You may never have heard of Hikvision, but chances are you’ve already been [more…]
[ad_1] Medicare’s prescription-drug program could save billions of dollars annually if it purchased generic [more…]
[ad_1] A new colorectal cancer drug has shocked researchers with how effective it is [more…]